Active not recruiting

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

I6T-MC-AMAJ - ClinicalTrials.gov - NCT03535194

The reason for this study is to see how effective and safe mirikizumab is compared to secukinumab and placebo for moderate to severe plaque psoriasis.
How long will I be in the trial?
The study will last about 56 weeks with 12 week follow-up and may include up to 20 visits.
Email
Active not recruiting

A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)

I6T-MC-AMAJ - ClinicalTrials.gov - NCT03535194

The reason for this study is to see how effective and safe mirikizumab is compared to secukinumab and placebo for moderate to severe plaque psoriasis.
How long will I be in the trial?
The study will last about 56 weeks with 12 week follow-up and may include up to 20 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participant must have chronic plaque psoriasis for at least 6 months

Participants must NOT

Participant must not be breastfeeding or nursing

Participant must not have had serious or chronic/recurring infection within 3 months

Participant must not have any other skin conditions (excluding psoriasis)

Participant must not have previous exposure to Cosentyx, Taltz, Stelara, or similar medications

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

Mirikizumab, Placebo, Secukinumab

Could I receive a Placebo?

yes

Enrollment Goal

1443

Trial Dates

June 2018 - December 2020

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participant must have chronic plaque psoriasis for at least 6 months

Participants must NOT

Participant must not be breastfeeding or nursing

Participant must not have had serious or chronic/recurring infection within 3 months

Participant must not have any other skin conditions (excluding psoriasis)

Participant must not have previous exposure to Cosentyx, Taltz, Stelara, or similar medications

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

Mirikizumab, Placebo, Secukinumab

Could I receive a Placebo?

yes

Enrollment Goal

1443

Trial Dates

June 2018 - December 2020

Trial Phase

3

Not the right fit? Sign up to receive updates on new Psoriasis trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Psoriasis Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?